Official Journal of the European Behavioural Pharmacology Society (EBPS)

Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal encompasses the following fields:

Human Psychopharmacology: Experimental

This section includes manuscripts describing the effects of drugs on mood, behavior, cognition and physiology in humans. The journal encourages submissions that involve brain imaging, genetics, neuroendocrinology, and developmental topics. Usually manuscripts in this section describe studies conducted under controlled conditions, but occasionally descriptive or observational studies are also considered.

Human Psychopharmacology: Clinical and Translational

This section comprises studies addressing the broad intersection of drugs and psychiatric illness. This includes not only clinical trials and studies of drug usage and metabolism, drug surveillance, and pharmacoepidemiology, but also work utilizing the entire range of clinically relevant methodologies, including neuroimaging, pharmacogenetics, cognitive science, biomarkers, and others. Work directed toward the translation of preclinical to clinical knowledge is especially encouraged. The key feature of submissions to this section is that they involve a focus on clinical aspects.

Preclinical psychopharmacology: Behavioral and Neural

This section considers reports on the effects of compounds with defined chemical structures on any aspect of behavior, in particular when correlated with neurochemical effects, in species other than humans. Manuscripts containing neuroscientific techniques in combination with behavior are welcome. We encourage reports of studies that provide insight into the mechanisms of drug action, at the behavioral and molecular levels.

Preclinical Psychopharmacology: Translational

This section considers manuscripts that enhance the confidence in a central mechanism that could be of therapeutic value for psychiatric or neurological patients, using disease-relevant preclinical models and tests, or that report on preclinical manipulations and challenges that have the potential to be translated to the clinic. Studies aiming at the refinement of preclinical models based upon clinical findings (back-translation) will also be considered. The journal particularly encourages submissions that integrate measures of target tissue exposure, activity on the molecular target and/or modulation of the targeted biochemical pathways.

Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic

This section focuses on the molecular and cellular actions of neuropharmacological agents / drugs, and the identification / validation of drug targets affecting the CNS in health and disease. We particularly encourage studies that provide insight into the mechanisms of drug action at the molecular level. Manuscripts containing evidence for genetic or epigenetic effects on neurochemistry or behavior are welcome.

The journal welcomes submissions in all of these fields.

Details Concerning the Submission and Publication Procedures:
- No Page Charges
- No Fees for Online Color Images
- Optional Color Images in Print – EUR 950/USD 1150. VAT or local taxes will be added where applicable.
- Optional Open Access Publication Fee (APC) - EUR 2990/USD 3760/GBP 2490. VAT or local taxes will be added where applicable.

  • Publishes research and reviews of mechanisms by which drugs affect behavior
  • Extends from clinical psychopharmacology to studies of effects of drugs on human cognition and behavior
  • Covers methodologies from neurochemical assays to functional neuroimaging studies

Journal information

Principal Editor
  • Diego Pizzagalli,
  • James Stone,
  • Debra Bangasser,
  • Mitul A. Mehta,
  • Kenji Hashimoto,
  • Stan B. Floresco,
  • Deepak Cyril D'Souza
Coordinating Editor
  • Trevor W. Robbins,
  • Christelle Baunez,
  • Patricia H. Janak
Publishing model
Hybrid (Transformative Journal). How to publish with us, including Open Access

Journal metrics

4.530 (2020)
Impact factor
4.077 (2020)
Five year impact factor
47 days
Submission to first decision (Median)
1,327,532 (2021)
Downloads

Latest articles

Journal updates

View all updates

About this journal

Electronic ISSN
1432-2072
Print ISSN
0033-3158
Abstracted and indexed in
  1. ANVUR
  2. BFI List
  3. BIOSIS
  4. Baidu
  5. Biological Abstracts
  6. CAB Abstracts
  7. CLOCKSS
  8. CNKI
  9. CNPIEC
  10. Chemical Abstracts Service (CAS)
  11. Current Contents/ Life Sciences
  12. Dimensions
  13. EBSCO Academic Search
  14. EBSCO Advanced Placement Source
  15. EBSCO Biomedical Reference Collection
  16. EBSCO CINAHL
  17. EBSCO Discovery Service
  18. EBSCO Psychology & Behavioral Sciences Collection
  19. EBSCO Rehabilitation & Sports Medicine Source
  20. EBSCO SPORTDiscus
  21. EBSCO STM Source
  22. EMBASE
  23. ERIH PLUS
  24. Gale
  25. Google Scholar
  26. IFIS Publishing
  27. Japanese Science and Technology Agency (JST)
  28. Journal Citation Reports/Science Edition
  29. Medline
  30. Meta
  31. Naver
  32. Norwegian Register for Scientific Journals and Series
  33. OCLC WorldCat Discovery Service
  34. Pathway Studio
  35. Portico
  36. ProQuest Animal Behavior Abstracts
  37. ProQuest-ExLibris Primo
  38. ProQuest-ExLibris Summon
  39. PsycINFO
  40. Reaxys
  41. SCImago
  42. SCOPUS
  43. Science Citation Index
  44. Science Citation Index Expanded (SCIE)
  45. TD Net Discovery Service
  46. UGC-CARE List (India)
  47. Wanfang
Copyright information

Rights and permissions

Springer policies

© Springer-Verlag GmbH Germany, part of Springer Nature